Yidianjun
一点君
Yidianjun
Consumer/E-commerce
It enables precise management of uric acid/gout levels while also lifting dietary restrictions, and is revolutionary in achieving uric acid reduction and liver and kidney protection simultaneously.
Latest round: Pre Series A (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-08-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.